The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence

BJU International

Volumn 95, Issue 7, 2005, Pages 1077-1080

  Chen, Kuo Chiang ^b   Minor, Thomas X ^a   Rahman, Nadeem U ^a   Ho, Hao Chung ^c   Nunes, Lora ^a   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Brain derived neurotrophic factor; Erectile dysfunction; Neurogenic impotence; Vascular endothelial growth factor

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; PHOSPHATE; RECOMBINANT VASCULOTROPIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ELECTROSTIMULATION; ERECTILE DYSFUNCTION; FREEZING; IMPOTENCE; MALE; MONOTHERAPY; NERVE REGENERATION; NEUROGENIC IMPOTENCE; NONHUMAN; PENIS ERECTION; PENIS INJURY; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ADENOVIRIDAE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; IMPOTENCE; INJECTIONS; MALE; NERVE REGENERATION; PENILE ERECTION; PENIS; RATS; RATS, SPRAGUE-DAWLEY; TRAUMA, NERVOUS SYSTEM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 18544367145     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05470.x     Document Type: Article

References (24)

1. Burnett AL, Wesselmann U. History of the neurobiology of the pelvis. Urology 1999; 53: 1082-9
2. Nehra A, Moreland RB. Neurologic erectile dysfunction. Urol Clin North Am 2001; 28: 289-308
3. Paick JS, Donatucci CF, Lue TF. Anatomy of cavernous nerves distal to prostate: microdissection study in adult male cadavers. Urology 1993; 42: 145-9
4. Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 1984; 56: 694-7
5. Litwin MS, Hays RD, Fink A et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35
6. Talcott JA, Rieker P, Propert KJ et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997; 89: 1117-23
7. Hara I, Kawabata G, Miyake H et al. Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer. J Urol 2003; 169: 2045-8
8. Hollenbeck BK, Dunn RL, Wei JT, Montie JE, Sanda MG. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol 2003; 169: 1453-7
9. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995; 153: 1722-7
10. Jung GW, Spencer EM, Lue TF. Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats. J Urol 1998; 160: 1899-904
11. Bochinski DHP, Nunes L, Lin GT, Lin CS, Spencer EM, Lue TF. Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res 2004; 16: 418-243
12. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1: 549-53
13. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994; 77: 627-38
14. Acheson A, Conover JC, Fandl JP et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 450-3
15. Johnson EM Jr, Taniuchi M, DiStefano PS. Expression and possible function of nerve growth factor receptors on Schwann cells. Trends Neurosci 1988; 11: 299-304
16. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360: 753-5
17. Bakircioglu ME, Lin CS, Fan P, Sievert KD, Kan YW, Lue TF. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol 2001; 165: 2103-9
18. Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab Invest 1997; 76: 245-55
19. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19: 5731-40
20. Lin CS, Ho HC, Chen KC, Lin G, Nunes L, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int 2002; 89: 955-60
21. Hsieh PS, Bochinski DJ, Lin GT, Nunes L, Lin CS, Lue TF. The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int 2003; 92: 470-5
22. El-Sakka AI, Hassan MU, Selph C, Lue TF. Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia. J Urol 1998; 160: 2245
23. Gholami SS, Rogers R, Chang J et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577-81
24. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761-7